ABAC THERAPEUTICS
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
ABAC
EXIT
Discovery and development of first-in-class precisión antimicrobial agents for treatment of MDR infections. ABAC shall extensively apply the PasNas Technology Platform to discover novel active compounds to fight infections caused by MDR bacteria.
Industries & Technologies
Financial data
Other information
Funding
(November 2019)
Acquisition
Investors: Advanded Biotechnologies Investment SL
16M € (November 2019)
Minority stake unknown %
Investors: PONTIFAX, GLOBAL HEALTH SCIENCE FUND, CAIXA CAPITAL RISC, DEBIOPHARM INNOVATION FUND Y FERRER
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
Other startups near startup ABAC
similar companies
- Healthtech
- Hardware
- Robotics & Collaborative Robotics
- AI & Big Data
- IoT & Sensors
- Digital Health
- Medical devices
- Social Economy
- Deeptech
- Healthtech
- Hardware
- Sustainable mobility
- Robotics & Collaborative Robotics
- AI & Big Data
- Cloud & Edge Computing
- Connectivity
- Digital Health
- Industry 4.0
- Deeptech
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.